Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1684460

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1684460

Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

PUBLISHED:
PAGES: 181 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Persistence Market Research has recently released a comprehensive report on the worldwide market for colon screening. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

  • Colon Screening Market Size (2025E): US$ 18.7 Bn
  • Projected Market Value (2032F): US$ 24.45 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening plays a crucial role in the early detection and prevention of colorectal cancer, one of the leading causes of cancer-related deaths worldwide. Screening methods such as colonoscopy, stool-based tests, and imaging techniques help identify precancerous polyps and early-stage malignancies, significantly improving patient outcomes. The colon screening market serves hospitals, diagnostic laboratories, ambulatory surgical centers, and home healthcare settings, offering a range of screening technologies, including fecal immunochemical tests (FIT), stool DNA tests, sigmoidoscopy, and CT colonography. Market growth is driven by the rising prevalence of colorectal cancer, increasing awareness of early detection benefits, and advancements in screening technologies that enhance accuracy and accessibility.

Market Growth Drivers:

The global colon screening market is propelled by several key factors, including the growing burden of colorectal cancer due to changing dietary habits, aging populations, and sedentary lifestyles. Government initiatives promoting routine screening programs and favorable reimbursement policies further accelerate market expansion. Technological advancements, such as artificial intelligence (AI)-assisted colonoscopy, liquid biopsy tests, and non-invasive screening solutions, enhance diagnostic precision and patient compliance. Additionally, the increasing adoption of home-based and self-administered screening kits provides new avenues for market growth, particularly in regions with limited access to healthcare facilities.

Market Restraints:

Despite promising growth prospects, the colon screening market faces challenges related to high procedure costs, limited access to screening in low-income regions, and patient reluctance due to invasive test methods. Regulatory hurdles and stringent approval processes for new screening technologies also pose market entry barriers for manufacturers. Furthermore, disparities in awareness and screening adherence rates across different demographic groups impact overall market penetration. Addressing these challenges requires collaborative efforts from healthcare providers, governments, and industry stakeholders to enhance screening affordability, education, and accessibility.

Market Opportunities:

The colon screening market presents significant growth opportunities driven by technological innovations, strategic partnerships, and expanding healthcare infrastructure. The integration of AI in diagnostic imaging, liquid biopsy development for non-invasive early detection, and advancements in at-home screening kits open new frontiers for market players. Telemedicine and digital health platforms further facilitate patient engagement and follow-up care, improving screening adherence rates. Additionally, increased funding for cancer research and early detection initiatives creates a favorable landscape for product development and market expansion. Companies investing in cost-effective, high-accuracy screening solutions stand to gain a competitive advantage in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the colon screening market globally?
  • Which screening technologies and methods are gaining the most traction across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the colon screening market?
  • Who are the key players contributing to the colon screening market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the global colon screening market, including Exact Sciences Corporation, Abbott Laboratories, Siemens Healthineers, and Olympus Corporation, focus on innovation, regulatory approvals, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop next-generation screening technologies, such as AI-driven colonoscopy tools, liquid biopsy solutions, and enhanced stool-based tests, catering to diverse patient needs. Partnerships with healthcare providers, insurance companies, and diagnostic laboratories facilitate market access and promote screening adoption. Additionally, initiatives aimed at increasing patient awareness, physician training, and government collaborations further strengthen market penetration.

Key Companies Profiled:

  • Exact Sciences Corporation
  • Abbott Laboratories
  • Siemens Healthineers
  • Olympus Corporation
  • Medtronic Plc
  • Quest Diagnostics Incorporated
  • Epigenomics AG
  • Natera, Inc.
  • Guardant Health, Inc.
  • Eiken Chemical Co., Ltd.

Colon Screening Industry Segmentation

By Screening Type

  • Stool-Based Tests
  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy

By Product Type

  • Endoscopes
  • CT Scanners
  • Capsule Endoscopes
  • Test Kits & Reagents

By End User

  • Hopitals
  • Diagnostic & Imaging Centers
  • Research & Academic Institutions

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America
Product Code: PMRREP35162

Table of Contents

1. Executive Summary

  • 1.1. Global Colon Screening Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Colon Screening Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Colon Screening Market Outlook: Screening Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Screening Type,2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
      • 4.3.3.1. Stool-Based Tests
        • 4.3.3.1.1. Fecal Immunochemical Test (FIT)
        • 4.3.3.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
        • 4.3.3.1.3. Others
      • 4.3.3.2. Colonoscopy
      • 4.3.3.3. Flexible Sigmoidoscopy
      • 4.3.3.4. Capsule Endoscopy
      • 4.3.3.5. Others
    • 4.3.4. Market Attractiveness Analysis: Screening Type
  • 4.4. Global Colon Screening Market Outlook: Product Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type,2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.4.3.1. Endoscopes
      • 4.4.3.2. CT Scanners
      • 4.4.3.3. Capsule Endoscopes
      • 4.4.3.4. Test Kits & Reagents
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Colon Screening Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User,2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic & Imaging Centers
      • 4.5.3.3. Research & Academic Institutions
      • 4.5.3.4. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Colon Screening Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region,2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Colon Screening Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Screening Type
    • 6.2.3. By Product Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 6.4.1. Stool-Based Tests
      • 6.4.1.1. Fecal Immunochemical Test (FIT)
      • 6.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 6.4.1.3. Others
    • 6.4.2. Colonoscopy
    • 6.4.3. Flexible Sigmoidoscopy
    • 6.4.4. Capsule Endoscopy
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.5.1. Endoscopes
    • 6.5.2. CT Scanners
    • 6.5.3. Capsule Endoscopes
    • 6.5.4. Test Kits & Reagents
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic & Imaging Centers
    • 6.6.3. Research & Academic Institutions
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Colon Screening Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Screening Type
    • 7.2.3. By Product Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 7.4.1. Stool-Based Tests
      • 7.4.1.1. Fecal Immunochemical Test (FIT)
      • 7.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 7.4.1.3. Others
    • 7.4.2. Colonoscopy
    • 7.4.3. Flexible Sigmoidoscopy
    • 7.4.4. Capsule Endoscopy
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.5.1. Endoscopes
    • 7.5.2. CT Scanners
    • 7.5.3. Capsule Endoscopes
    • 7.5.4. Test Kits & Reagents
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic & Imaging Centers
    • 7.6.3. Research & Academic Institutions
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Colon Screening Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Screening Type
    • 8.2.3. By Product Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 8.4.1. Stool-Based Tests
      • 8.4.1.1. Fecal Immunochemical Test (FIT)
      • 8.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 8.4.1.3. Others
    • 8.4.2. Colonoscopy
    • 8.4.3. Flexible Sigmoidoscopy
    • 8.4.4. Capsule Endoscopy
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.5.1. Endoscopes
    • 8.5.2. CT Scanners
    • 8.5.3. Capsule Endoscopes
    • 8.5.4. Test Kits & Reagents
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic & Imaging Centers
    • 8.6.3. Research & Academic Institutions
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Colon Screening Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Screening Type
    • 9.2.3. By Product Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 9.4.1. Stool-Based Tests
      • 9.4.1.1. Fecal Immunochemical Test (FIT)
      • 9.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 9.4.1.3. Others
    • 9.4.2. Colonoscopy
    • 9.4.3. Flexible Sigmoidoscopy
    • 9.4.4. Capsule Endoscopy
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.5.1. Endoscopes
    • 9.5.2. CT Scanners
    • 9.5.3. Capsule Endoscopes
    • 9.5.4. Test Kits & Reagents
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic & Imaging Centers
    • 9.6.3. Research & Academic Institutions
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Colon Screening Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Screening Type
    • 10.2.3. By Product Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 10.4.1. Stool-Based Tests
      • 10.4.1.1. Fecal Immunochemical Test (FIT)
      • 10.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 10.4.1.3. Others
    • 10.4.2. Colonoscopy
    • 10.4.3. Flexible Sigmoidoscopy
    • 10.4.4. Capsule Endoscopy
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.5.1. Endoscopes
    • 10.5.2. CT Scanners
    • 10.5.3. Capsule Endoscopes
    • 10.5.4. Test Kits & Reagents
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic & Imaging Centers
    • 10.6.3. Research & Academic Institutions
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Colon Screening Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Screening Type
    • 11.2.3. By Product Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 11.4.1. Stool-Based Tests
      • 11.4.1.1. Fecal Immunochemical Test (FIT)
      • 11.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 11.4.1.3. Others
    • 11.4.2. Colonoscopy
    • 11.4.3. Flexible Sigmoidoscopy
    • 11.4.4. Capsule Endoscopy
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.5.1. Endoscopes
    • 11.5.2. CT Scanners
    • 11.5.3. Capsule Endoscopes
    • 11.5.4. Test Kits & Reagents
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic & Imaging Centers
    • 11.6.3. Research & Academic Institutions
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Olympus Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. PENTAX Medical (Hoya Corporation)
    • 12.3.3. FUJIFILM Holdings Corporation
    • 12.3.4. Medtronic
    • 12.3.5. Ambu A/S
    • 12.3.6. Baxter (Hillrom & Welch Allyn)
    • 12.3.7. EndoFresh
    • 12.3.8. (Daichuan medical)
    • 12.3.9. Bracco
    • 12.3.10. Varay Laborix
    • 12.3.11. QuidelOrtho Corporation
    • 12.3.12. Novigenix SA
    • 12.3.13. Guardant Health, Inc.
    • 12.3.14. Mainz Biomed N.V.
    • 12.3.15. Eiken Chemical Co., Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!